Orion Enters Collaboration Agreement with Evofem Biosciences to Develop Novel Product for Women’s Health
Evofem Biosciences and Orion announced that we have entered into a collaboration agreement to evaluate the compatibility and stability of Orion’s novel CCR5 antagonist, OB-002, in Evofem’s Phexxi® vaginal gel with the goal of developing a Multipurpose Prevention Technology (MPT) product for indications including the prevention of HIV …